Data deals: Week 38, 2026 (14 Sept to 20 Sept)
8 deals announced this week. ✓ Reviewed: read and analysed by Gianluca. Others are short summaries of the public record.
- 2026-09-18 · IEX Group · Pico
IEX launches vendor partnership program with revenue share on new subscriptions to IEX market data
On 18 September 2026, IEX Group announced a vendor partnership program offering participating vendors a revenue share tied to qualifying new client subscriptions to IEX market data products for a period of time. Eligible products are IEX TOPS, IEX DEEP and IEX DEEP+. Stacie Swanstrom, Global Head of Market Services at Pico, was quoted in the announcement.
- 2026-09-18 · Infillion · Foursquare
Infillion acquires Foursquare to pair location visitation data with Catalina purchase data for ad attribution✓
Infillion is acquiring Foursquare, announced 18 September 2026, terms undisclosed. The deal joins Foursquare's 16 billion check-ins and 250M-device U.S. coverage with Catalina's household purchase records, which Infillion bought in February 2026. One owner can now link an ad impression to a store visit and a till transaction, ending Foursquare's prior sale of visitation data to rival agencies and platforms.
- 2026-09-16 · Memorial Sloan Kettering Cancer Center · OpenEvidence
MSK and OpenEvidence partner to integrate OncoKB into OpenEvidence and OpenEvidence into MSK's Epic
On September 16, 2026, Memorial Sloan Kettering Cancer Center and OpenEvidence announced a partnership integrating MSK's OncoKB precision oncology knowledge base into OpenEvidence for providers, and integrating OpenEvidence into MSK's Epic electronic health records workflow.
- 2026-09-16 · OpenText · Cohere
OpenText and Cohere partner to combine trusted data with agentic AI
OpenText published a press release titled 'OpenText, Cohere Partner to Combine Trusted Data with Agentic AI' announcing a partnership with Cohere.
- 2026-09-16 · Twist Bioscience · Eli Lilly
Twist Bioscience joins Lilly TuneLab as preferred antibody characterization data provider
On September 16, 2026, Twist Bioscience announced it has joined Eli Lilly's TuneLab as a preferred antibody characterization data provider, generating high-throughput wet lab antibody characterization data using TuneLab-specified protocols that feed into AbLab, Lilly's antibody developability prediction model. Financial terms were not disclosed.
- 2026-09-15 · Tempus AI
Tempus AI discloses ~$200M Q2 data-licensing TCV and 36% growth at Morgan Stanley healthcare conference
On 15 September 2026, Tempus AI CEO Eric Lefkofsky told the Morgan Stanley 24th Annual Global Healthcare Conference that its data licensing business grew about 36% last quarter, with the latest quarter reaching about $200 million in total contract value bookings and marking the third consecutive quarter above $100 million in TCV.
- 2026-09-15 · Century Health · Eye Health America
Century Health and Eye Health America partner to build de-identified retinal disease RWD dataset
On 15 September 2026, Century Health and Eye Health America (EHA) announced a partnership to transform ophthalmology clinical data into research-grade datasets for real-world evidence generation and life sciences research on chronic retinal conditions, including diabetic retinopathy and age-related macular degeneration.
- 2026-09-15 · Datavant · Neuberger · KKR · New Mountain Capital
Neuberger and KKR agree significant minority stake in health-data platform Datavant alongside New Mountain✓
On 15 September 2026, Neuberger and KKR agreed to take an equity stake in Datavant, the US health records network reaching 80,000+ providers and 75 of the top 100 US health systems. New Mountain Capital, invested since 2014, keeps its controlling position. Terms were not disclosed and closing is expected in Q4 2026.